Masaaki Noguchi

Urayasu, 2790021, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Successful combination therapy with fostamatinib and romiplostim in refractory immune thrombocytopenia 27 years after onset

Successful combination therapy with fostamatinib and romiplostim in refractory immune thrombocytopenia 27 years after onset

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 29, 2026

A New Histology-Based Prognostic Index for Acute Lymphoblastic Leukemia: Preliminary Results of the "ALL Urayasu Classification".

A New Histology-Based Prognostic Index for Acute Lymphoblastic Leukemia: Preliminary Results of the "ALL Urayasu Classification".

Journal: Journal of clinical medicine

Published: November 24, 2025

A New Histology-Based Prognostic Index for Acute Myeloid Leukemia: Preliminary Results for the "AML Urayasu Classification".

A New Histology-Based Prognostic Index for Acute Myeloid Leukemia: Preliminary Results for the "AML Urayasu Classification".

Journal: Journal of clinical medicine

Published: January 14, 2025

TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy.

TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy.

Journal: Annals of hematology

Published: December 21, 2024

Prognostic Factors in Patients with Acute Myeloid Leukemia Treated with the Combination of Venetoclax plus Azacitidine(VEN+AZA).

Prognostic Factors in Patients with Acute Myeloid Leukemia Treated with the Combination of Venetoclax plus Azacitidine(VEN+AZA).

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: December 08, 2024

A New Histology-Based Prognostic Index for Aggressive T-Cell lymphoma: Preliminary Results of the "TCL Urayasu Classification".

A New Histology-Based Prognostic Index for Aggressive T-Cell lymphoma: Preliminary Results of the "TCL Urayasu Classification".

Journal: Journal of clinical medicine

Published: April 10, 2024

A Case of Relapsed/Refractory CD56-Positive Acute Promyelocytic Leukemia, in Which Complete Molecular Remission Was Achieved Following Combination Therapy with Venetoclax and Azacitidine.

A Case of Relapsed/Refractory CD56-Positive Acute Promyelocytic Leukemia, in Which Complete Molecular Remission Was Achieved Following Combination Therapy with Venetoclax and Azacitidine.

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: March 18, 2024

Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma.

Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: December 26, 2023

Possible New Histological Prognostic Index for Large B-Cell Lymphoma.

Possible New Histological Prognostic Index for Large B-Cell Lymphoma.

Journal: Journal of clinical medicine

Published: August 16, 2023

Role of TGF-beta1 and TNF-alpha1 produced by neoplastic cells in the pathogenesis of fibrosis in patients with hematologic neoplasms.

Role of TGF-beta1 and TNF-alpha1 produced by neoplastic cells in the pathogenesis of fibrosis in patients with hematologic neoplasms.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: April 30, 2023

Development of rapidly fatal TAFRO syndrome-like features in a patient with essential thrombocythemia.

Development of rapidly fatal TAFRO syndrome-like features in a patient with essential thrombocythemia.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 29, 2023

Eosinophil-rich variant of nodal marginal zone lymphoma: a clinicopathological study of 11 cases.

Eosinophil-rich variant of nodal marginal zone lymphoma: a clinicopathological study of 11 cases.

Journal: Histopathology

Published: February 12, 2023

Showing 1-12 of 93

Last Updated: 09/26/2026